Biomerica Stock Options
| BMRA Stock | USD 0.71 0.01 0.97% |
Biomerica's option chain provides insight into all available option contracts written on Biomerica's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Biomerica's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Biomerica option contract.
In The Money vs. Out of Money Option Contracts on Biomerica
Analyzing Biomerica's in-the-money options over time can help investors to take a profitable long position in Biomerica regardless of its overall volatility. This is especially true when Biomerica's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Biomerica's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Biomerica's stock while costing only a fraction of its price.
Biomerica's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 372.04 with a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 70. This yields a 0.0 put-to-call volume ratio. The Biomerica option chain provides detailed quote and price information for the current Biomerica option contracts. It shows all of Biomerica's listed puts, calls, expiration dates, strike prices, and other pricing information.
The chart above shows Biomerica's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Biomerica's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Biomerica's option, there is no secondary market available for investors to trade.
Biomerica's stock options are financial instruments that give investors the right to buy or sell shares of Biomerica common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Biomerica stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Biomerica's stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. Please note that buying 'in-the-money' options on Biomerica lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Biomerica's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Biomerica contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Biomerica Stock moves the wrong way.
At present, Biomerica's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 17.1 M, whereas Common Stock Total Equity is forecasted to decline to about 622.7 K. Biomerica Current Options Market Mood
Biomerica's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Biomerica Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of Biomerica's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Biomerica's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Biomerica's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Biomerica contract
Base on the Rule 16, the options market is currently suggesting that Biomerica will have an average daily up or down price movement of about 23.25% per day over the life of the 2024-05-17 option contract. With Biomerica trading at USD 0.713, that is roughly USD 0.17. If you think that the market is fully incorporating Biomerica's daily price movement you should consider buying Biomerica options at the current volatility level of 372.04%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Biomerica |
Purchasing Biomerica options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Biomerica calls. Remember, the seller must deliver Biomerica stock to the call owner when a call is exercised.
Biomerica Option Chain
When Biomerica's strike price is surpassing the current stock price, the option contract against Biomerica stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Biomerica's option chain is a display of a range of information that helps investors for ways to trade options on Biomerica. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Biomerica. It also shows strike prices and maturity days for a Biomerica against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $2.5 | 0.1951 | 0.4089 | 144 | 2024-05-17 | 0.0 - 0.05 | 0.05 | Out |
Put | 2024-05-17 PUT at $7.5 | -0.3851 | 0.2152 | 0 | 2024-05-17 | 4.8 - 7.1 | 0.0 | In |
Put | 2024-05-17 PUT at $5.0 | -0.2675 | 0.1706 | 0 | 2024-05-17 | 2.6 - 4.7 | 0.0 | In |
Put | 2024-05-17 PUT at $2.5 | -0.0751 | 0.0551 | 0 | 2024-05-17 | 0.55 - 2.4 | 0.0 | In |
Biomerica Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Biomerica Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Biomerica Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biomerica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Biomerica Corporate Directors
Biomerica corporate directors refer to members of a Biomerica board of directors. The board of directors generally takes responsibility for the Biomerica's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biomerica's board members must vote for the resolution. The Biomerica board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Francis Cano | Independent Director | Profile | |
| Jane Emerson | Independent Director | Profile | |
| Janet Moore | CFO, Treasurer, Secretary and Director | Profile | |
| MBA PharmD | Executive Director of Medical Affairs and Research and Sr. Advisor | Profile |
Already Invested in Biomerica?
The danger of trading Biomerica is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biomerica is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biomerica. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biomerica is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.323 | Quarterly Revenue Growth (0.09) | Return On Assets (0.43) | Return On Equity (0.92) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.